Publication | Closed Access

Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer

Concurrent ChemoradiotherapyPhase Ii TrialRecombinant Human EndostatinMedicinePathologyBronchial NeoplasmCancer TreatmentOncologyRadiation OncologyLung Cancer